Joanne Jenkins, an oncology specialist, has joined iTeos Therapeutics SA as chief medical officer to help the Belgian company progress its portfolio of antibody therapeutics. She was previously head of global oncology development at Sanofi SA where she oversaw a portfolio of drugs targeting both haematologic and solid tumour malignancies. Before that, she headed a cancer metabolism discovery unit at GlaxoSmithKline Plc. Dr Lager received her MD from Duke University school of Medicine and a BA in psychobiology from Wellesley College, US.
iTeos announced the appointment on 26 March 2019
Copyright 2019 Evernow Publishing